1-20 of 48
Gurbakhash Kaur
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 registrational study of anitocabtagene autoleucel for the treatment of patients with relapsed and/or refractory multiple myeloma: Updated results from iMMagine–1

Free
Krina Patel, Binod Dhakal, Gurbakhash Kaur, Richard Maziarz, Natalie Callander, Adam Sperling, Carolina Schinke, Andrzej Jakubowiak, Noa Biran, Douglas Sborov, Cindy Varga, Larry Anderson, Abhinav Deol, Abraham Kanate, Mehmet Kocoglu, Melhem Solh, Kamalika Banerjee, Krishna Rana, Ana Kostic, Enrique Granados, Carolyn Jackson, Christopher Heery, Ciara Louise Freeman, Tim Welliver, Matthew Frigault
Journal: Blood
Blood (2025) 146 (Supplement 1): 256.
https://doi.org/10.1182/blood-2025-256
Published: 2025
Journal Articles

Prolonged cytopenias after BCMA CAR‑T are associated with impaired endogenous T cell recovery characterized by decreased CD8+ T cell diversity

Free
Abigail Chutnik, Zachary Avigan, Ramy Mahmoud, Alessandro Lagana, Matthew Croken, Meenakshi Mehrotra, Zahra Moinfar, Adriana Rossi, Shambavi Richard, Gurbakhash Kaur, Joshua Richter, Larysa Sanchez, Cesar Rodriguez Valdes, Hearn Cho, Sundar Jagannath, Mesude Bicak, Nina Bhardwaj, Jane Houldsworth, Santiago Thibaud, Samir Parekh
Journal: Blood
Blood (2025) 146 (Supplement 1): 2290.
https://doi.org/10.1182/blood-2025-2290
Published: 2025
Journal Articles

Development of predictive relapse indicators for myeloma T cell engagers (PRIME) model for myeloma patients receiving BCMA- and GPRC5D-targeting T cell engagers

Free
Tarek Mouhieddine, Tianxiang Sheng, Junia Vieira, Adolfo Aleman, Zachary Avigan, Ariel Siegel, Mujahid Quidwai, Jordan Lu, Mohammad Rattu, Santiago Thibaud, Gurbakhash Kaur, Shambavi Richard, Adriana Rossi, Hearn Cho, Alessandro Lagana, Samantha Stclair, Dalia Abdel Azim, Larysa Sanchez, Joshua Richter, Cesar Rodriguez Valdes, Christian Salib, Erin Moshier, Samir Parekh, Sundar Jagannath
Journal: Blood
Blood (2025) 146 (Supplement 1): 3996.
https://doi.org/10.1182/blood-2025-3996
Published: 2025
Journal Articles

S100A8/A9 drives T cell exhaustion and compromises the therapeutic efficacy of bispecific antibodies in multiple myeloma.

Free
Adolfo Aleman, Oliver Van Oekelen, Shriya Desai, Sidorela Reci, Leah Grossman, Rudra Prasad Dutta, Mathieu Desaunay, Junia Vieira, Rongbao Zhao, Rahul Sanawar, Mani Mohindru, Tarek Mouhieddine, Alessandro Lagana, Marta Larrayoz, Poulikos Poulikakos, Gurbakhash Kaur, Larysa Sanchez, Cesar Rodriguez Valdes, Santiago Thibaud, Adriana Rossi, Shambavi Richard, Joshua Richter, Hearn Cho, Jose A. Martinez-Climent, Amit Verma, Sundar Jagannath, Samir Parekh
Journal: Blood
Blood (2025) 146 (Supplement 1): 916.
https://doi.org/10.1182/blood-2025-916
Published: 2025
Journal Articles

Real world outcomes of bispecific T-cell engagers in plasma cell leukemia

Free
Mahmoud Gaballa, Kelley Julian, Aimaz Afrough, Doris Hansen, Utkarsh Goel, Andre De Menezes Silva Corraes, Danai Dima, Masooma Rana, Hitomi Hosoya, Lekha Mikkilineni, Lindsay Fogel, Shahzad Raza, Rahul Banerjee, Saurabh Zanwar, Oren Pasvolsky, Aishwarya Sannareddy, Azra Borogovac, James Davis, Kimberly Green, Noa Biran, Megan Herr, Leyla Shune, Evguenia Bhurtel, Shebli Atrash, Christopher Ferreri, Tiffany Richards, Muhammad Bilal Abid, Susan Bal, Hossam M. Ali, J Christine Ye, Shambavi Richard, Gurbakhash Kaur, Kenneth Shain, Omar Alexis Castaneda Puglianini, Adriana Rossi, Larry Anderson, Peter Voorhees, Jack Khouri, Surbhi Sidana, Andrew Portuguese, Murali Janakiram, Hans Lee, Yi Lin, Ariel Grajales-Cruz, Krina Patel, Douglas Sborov
Journal: Blood
Blood (2025) 146 (Supplement 1): 823.
https://doi.org/10.1182/blood-2025-823
Published: 2025
Journal Articles

Patient perspectives and preferences for step-up dosing and treatment with teclistamab and talquetamab: Insights from a patient survey

Free
Jay Hydren, Rachel Jensen, Jorge Arturo Hurtado Martinez, Jennifer Ahlstrom, Mason Barnes, Caitlin Costello, Gurbakhash Kaur, Meera Mohan, Francesca Cottini, Douglas Sborov, Shaji Kumar, Noopur Raje, Philippe Moreau, Maithili Deshpande, Niodita Gupta-Werner, Tonya Le Blanc, Jessica Fowler, Rahul Banerjee
Journal: Blood
Blood (2025) 146 (Supplement 1): 6354.
https://doi.org/10.1182/blood-2025-6354
Published: 2025
Journal Articles

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

Free
Denis Toskic, Mahesh Mansukhani, Ping Zhou, Stephanie Scalia, Xun Ma, Teresa Fogaren, Lisa X. Lee, Alfred Chung, Sascha Alexander Tuchman, Giada Bianchi, Amandeep Godara, Heather J. Landau, Susan Bal, Gurbakhash Kaur, Vaishali Sanchorawala, Gareth Morgan, Hashim Mann, Robert Allen Vescio, Chakra Chaulagain, Cindy Varga, Suzanne Lentzsch, Gheorghe Doros, Raymond Comenzo
Journal: Blood
Blood (2024) 144 (Supplement 1): 6874.
https://doi.org/10.1182/blood-2024-201755
Published: 2024
Journal Articles

Racial and Ethnic Differences in Outcomes of Multiple Myeloma Patients Treated with Idecabtagene Vicleucel or Ciltacabtagene Autoleucel

Free
Lauren C. Peres, Alicia Richards, Surbhi Sidana, Laura B. Oswald, Danai Dima, Aimaz Afrough, Leyla O. Shune, Shonali Midha, Omar Castaneda, Christopher Ferreri, James A Davis, Oren Pasvolsky, Christen M. Dillard, Megan M Herr, Mehmet H. Kocoglu, Shebli Atrash, Brandon Blue, Evguenia Ouchveridze, Joseph P. McGuirk, Charlotte B Wagner, Radhika Bansal, Patrick Costello, Kinaya Smith, Alex Lieberman-Cribbin, Gabriel De Avila, Sneha Purvey, Hitomi Hosoya, Lekha Mikkilineni, Gurbakhash Kaur, Mahmoud R. Gaballa, Peter A. Forsberg, Ciara Louise Freeman, Murali Janakiram, Myo Htut, Sireesha Asoori, Nilesh Kalariya, Djordje Atanackovic, Binod Dhakal, Jack Khouri, Shahzad Raza, Ran Reshef, Melissa Alsina, Frederick L. Locke, Omar Nadeem, Faiz Anwer, Larry D Anderson, Jr., Shambavi Richard, Yi Lin, Thomas Martin, Peter M. Voorhees, Krina K. Patel, Doris K. Hansen, Douglas W Sborov
Journal: Blood
Blood (2024) 144 (Supplement 1): 3785.
https://doi.org/10.1182/blood-2024-210078
Published: 2024
Journal Articles

Predictors and Characterization of Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) in Patients with Multiple Myeloma Receiving Teclistamab

Free
Oren Pasvolsky, Aimaz Afrough, Lei Feng, Wenli Dong, Tiffany Richards, James A Davis, Danai Dima, Ariel Grajales-Cruz, Mariola A Vazquez-Martinez, Aishwarya Sannareddy, Utkarsh Goel, Rahul Banerjee, Mahmoud R. Gaballa, Alex Lieberman-Cribbin, Masooma S Rana, Kelley Julian, Christopher J Ferreri, Leyla O. Shune, Shaun DeJarnette, Evguenia Ouchveridze, Sandra Susanibar-Adaniya, Andrew J. Portuguese, Peter A. Forsberg, Hitomi Hosoya, Lekha Mikkilineni, Gurbakhash Kaur, Adriana Rossi, Megan M Herr, Erin Eberwein, Chenyu Lin, Brandon Blue, Shahzad Raza, Yi Lin, Joseph P. McGuirk, Shebli Atrash, Douglas W Sborov, Peter M. Voorhees, Faiz Anwer, Doris K. Hansen, Krina K. Patel, Surbhi Sidana, Andrew J. Cowan, Larry D Anderson, Jr., Shambavi Richard, Alfred L. Garfall, Hans C. Lee, Jack Khouri
Journal: Blood
Blood (2024) 144 (Supplement 1): 3337.
https://doi.org/10.1182/blood-2024-206357
Published: 2024
Journal Articles

Prevalent Treatment Patterns of Teclistamab and Talquetamab for Multiple Myeloma (MM): Experience from 609 Patients

Free
Farheen Chunara, Mansi R. Shah, Nishi Shah, Jessica Kent, Ghulam Rehman Mohyuddin, Sabarinath V Radhakrishnan, Gurbakhash Kaur, Rajshekhar Chakraborty, Leo Rasche, Carolina Schinke, Anita D'Souza, Aniko Szabo, Meera Mohan
Journal: Blood
Blood (2024) 144 (Supplement 1): 2394.
https://doi.org/10.1182/blood-2024-201599
Published: 2024
Journal Articles

Dexamethasone Is Associated with Cataracts in Multiple Myeloma Even after Adjusting for Age: Results of a Large Cross-Sectional Survey

Free
Rahul Banerjee, Jorge Arturo Hurtado Martinez, Mason S. Barnes, Patricia Alejandra Flores Pérez, Jay R. Hydren, Jennifer M. Ahlstrom, Kara I. Cicero, Gurbakhash Kaur, Parisa Taravati, Andrew J. Cowan
Journal: Blood
Blood (2024) 144 (Supplement 1): 7828.
https://doi.org/10.1182/blood-2024-201803
Published: 2024
Journal Articles

Post-CAR-T Driving Restrictions after Week 4 Appear Unnecessary: Data from the United States Myeloma Immunotherapy Consortium

Free
Rahul Banerjee, Alicia Richards, Jack Khouri, Murali Janakiram, Kara I. Cicero, Danai Dima, Mehmet H. Kocoglu, Leyla O. Shune, Evguenia Ouchveridze, Tania Jain, Aimaz Afrough, Saurabh Zanwar, Christopher Ferreri, Oren Pasvolsky, Lekha Mikkilineni, Sneha Purvey, Lauren C. Peres, Ciara Louise Freeman, Shonali Midha, Amer Beitinjaneh, James A Davis, Charlotte B Wagner, Megan M Herr, Peter A. Forsberg, Douglas W. Sborov, Shambavi Richard, Ran Reshef, Binod Dhakal, Veronika Bachanova, Joseph P. McGuirk, Peter M. Voorhees, Larry D Anderson, Jr., Yi Lin, Thomas G Martin, Surbhi Sidana, Krina K. Patel, Doris K. Hansen, Andrew J. Cowan, Gurbakhash Kaur
Journal: Blood
Blood (2024) 144 (Supplement 1): 3765.
https://doi.org/10.1182/blood-2024-199609
Published: 2024
Journal Articles

Phase 2 Registrational Study of Anitocabtagene Autoleucel for the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma: Preliminary Results from the IMMagine-1 Trial

Free
Ciara Louise Freeman, Binod Dhakal, Gurbakhash Kaur, Richard T. Maziarz, Natalie Callander, Adam S. Sperling, Carolina Schinke, Andrzej J Jakubowiak, Noa Biran, Douglas W Sborov, Cindy Varga, Abhinav Deol, Abraham S. Kanate, Mehmet Hakan Koçoğlu, Melhem M. Solh, Kamalika Banerjee, Rebecca Chan, Myrna Nahas, Ana Kostic, Enrique Granados, Carolyn Jackson, Christopher R. Heery, Tim Welliver, Krina K. Patel, Matthew Frigault
Journal: Blood
Blood (2024) 144 (Supplement 1): 1031.
https://doi.org/10.1182/blood-2024-198499
Published: 2024
Journal Articles

Upfront Use of Anti-CD38 Monoclonal Antibodies Is Associated with Improvement in Renal Failure in Multiple Myeloma: A Flatiron Real World Analysis from 2010 to 2023

Free
Adeel M Khan, Zimu Gong, Tanushree Prasad, Rahul Banerjee, Srija Shankar, Aimaz Afrough, Larry D Anderson, Jr., Meera Mohan, Gurbakhash Kaur
Journal: Blood
Blood (2024) 144 (Supplement 1): 3792.8.
https://doi.org/10.1182/blood-2024-210930
Published: 2024
Journal Articles

MRD-Guided Sequential Therapy for Deep Response in Newly Diagnosed Multiple Myeloma (NDMM)- Master-2 Trial

Free
Binod Dhakal, Rebecca Silbermann, Timothy M Schmidt, Eva Medvedova, Susan Bal, Smith Giri, Naresh Bumma, Abdullah Mohammad Khan, Andrew J. Cowan, Rajshekhar Chakraborty, Gayathri Ravi, Kelly Godby, Bhagirathbhai Dholaria, Muhamed Baljevic, Bria Gendron, Aimaz Afrough, Gurbakhash Kaur, Mary Kwok, Rahul Banerjee, Zhubin Ghavari, Anita D'Souza, Othman S. Akhtar, Meera Mohan, Henning Schade, Ravi Narra, Yubin Kang, Jeffrey V Matous, Larry D Anderson, Jr., Natalie Callander, Luciano J. Costa
Journal: Blood
Blood (2024) 144 (Supplement 1): 2000.1.
https://doi.org/10.1182/blood-2024-200210
Published: 2024
Journal Articles

Outcomes of Teclistamab (Tec) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) with Prior Exposure to BCMA-Directed Therapy (BCMA-DT): A Multicenter Study from the U.S. Multiple Myeloma Immunotherapy Consortium

Free
Danai Dima, Mariola A Vazquez-Martinez, James A Davis, Utkarsh Goel, Aimaz Afrough, Aishwarya Sannareddy, Oren Pasvolsky, Beatrice Razzo, Rahul Banerjee, Jack Khouri, Ariel Grajales-Cruz, Alex Lieberman-Cribbin, Masooma Shifa Rana, Kelley Julian, Shaun DeJarnette, Andrew J Portuguese, Mahmoud R. Gaballa, Gabriel De Avila, Sandra Susanibar-Adaniya, Shahzad Raza, Megan M Herr, Evguenia Ouchveridze, Tiffany Richards, Hitomi Hosoya, Lekha Mikkilineni, Gurbakhash Kaur, Daniel Schrum, Omar Castaneda, Adriana Rossi, Chenyu Lin, Peter A. Forsberg, Yi Lin, Shebli Atrash, Douglas W Sborov, Kenneth H. Shain, Peter M. Voorhees, Shambavi Richard, Alfred L. Garfall, Doris K. Hansen, Surbhi Sidana, Krina K. Patel, Andrew J. Cowan, Larry D Anderson, Jr., Hans C. Lee, Faiz Anwer, Christopher Ferreri, Leyla O. Shune
Journal: Blood
Blood (2024) 144 (Supplement 1): 897.
https://doi.org/10.1182/blood-2024-203409
Published: 2024
Journal Articles

Comparative Safety and Efficacy of Ciltacabtagene Autoleucel and Idecabtagene Vicleucel CAR T-Cell Therapies in Relapsed or Refractory Multiple Myeloma

Free
Doris K. Hansen, Lauren C. Peres, Danai Dima, Alicia Richards, Leyla O. Shune, Aimaz Afrough, Shonali Midha, Binod Dhakal, Mehmet H. Kocoglu, Shebli Atrash, Chris Ferreri, Omar Castaneda, James A Davis, Evguenia Ouchveridze, Joseph P. McGuirk, Charlotte B Wagner, Radhika Bansal, Patrick Costello, Kinaya Smith, Alex Lieberman-Cribbin, Gabriel De Avila, Sneha Purvey, Hitomi Hosoya, Lekha Mikkilineni, Laura B. Oswald, Gurbakhash Kaur, Oren Pasvolsky, Mahmoud R. Gaballa, Megan M Herr, Peter A. Forsberg, Murali Janakiram, Myo Htut, Sireesha Asoori, Nilesh Kalariya, Hamza Hashmi, Ran Reshef, Douglas W Sborov, Omar Nadeem, Faiz Anwer, Jack Khouri, Shahzad Raza, Djordje Atanackovic, Melissa Alsina, Ciara Louise Freeman, Frederick L. Locke, Peter M. Voorhees, Larry D Anderson, Jr., Shambavi Richard, Thomas Martin, Yi Lin, Krina K. Patel, Surbhi Sidana
Journal: Blood
Blood (2024) 144 (Supplement 1): 936.
https://doi.org/10.1182/blood-2024-194390
Published: 2024
Journal Articles

Outcomes of Elderly Patients with Relapsed Refractory Multiple Myeloma (RRMM) Treated with Teclistamab: A Multicenter Study from the U.S. Multiple Myeloma Immunotherapy Consortium

Free
Oren Pasvolsky, Danai Dima, Lei Feng, Wenli Dong, Tiffany Richards, James A Davis, Aimaz Afrough, Mariola A Vazquez-Martinez, Aishwarya Sannareddy, Utkarsh Goel, Rahul Banerjee, Jack Khouri, Frances N. Cervoni Curet, Mahmoud R. Gaballa, Alex Lieberman-Cribbin, Masooma S Rana, Kelley Julian, Christopher J Ferreri, Leyla O. Shune, Shaun DeJarnette, Evguenia Ouchveridze, Sandra Susanibar-Adaniya, Andrew J. Portuguese, Hitomi Hosoya, Lekha Mikkilineni, Gurbakhash Kaur, Adriana Rossi, Megan M Herr, Daniel Schrum, Chenyu Lin, Shahzad Raza, Yi Lin, Shebli Atrash, Joseph P. McGuirk, Douglas W Sborov, Peter M. Voorhees, Faiz Anwer, Melissa Alsina, Ciara Louise Freeman, Alfred L. Garfall, Surbhi Sidana, Andrew J. Cowan, Larry D Anderson, Jr., Doris K. Hansen, Shambavi Richard, Krina K. Patel, Hans C. Lee, Ariel Grajales-Cruz
Journal: Blood
Blood (2024) 144 (Supplement 1): 934.
https://doi.org/10.1182/blood-2024-205989
Published: 2024
Journal Articles

Selinexor, Ixazomib, Pomalidomide and Dexamethasone in Functionally High-Risk Multiple Myeloma: Results from the Myeloma Developing Regimens Using Genomics (MyDRUG) Sub-Protocol Y3

Free
Joshua Richter, Jeffrey A. Zonder, Nitya Nathwani, Giada Bianchi, Craig C. Hofmeister, Ravi Vij, Matthew Pianko, Gurbakhash Kaur, Malin Hultcrantz, Katie Wozniak, Mercedes Martillo, Hearn Jay Cho, Shaji Kunnathu Kumar
Journal: Blood
Blood (2023) 142 (Supplement 1): 3387.
https://doi.org/10.1182/blood-2023-184949
Published: 2023
Journal Articles

Toxicity and Efficacy Outcomes of Teclistamab in Patients with Relapsed-Refractory Multiple Myeloma (RRMM) Above the Age of 70 Years: A Multicenter Study

Free
Danai Dima, Aishwarya Sannareddy, Nausheen Ahmed, James A Davis, Hira Shaikh, Zahra Mahmoudjafari, Marissa Duco, Jack Khouri, Gurbakhash Kaur, Jonathan Lochner, Faiz Anwer, Aimaz Afrough, Jason Valent, Hamza Hashmi, Al-Ola Abdallah
Journal: Blood
Blood (2023) 142 (Supplement 1): 3330.
https://doi.org/10.1182/blood-2023-180458
Published: 2023